At least 20 coronavirus vaccines are already in development, World Health Organization says

Grant Boone
March 23, 2020

"The more vaccine we can provide sooner, the better", he added.

The deputy director of the National Infection Service under PHE, Miles Carroll, said the body is "uniquely positioned to support and drive the country's hunt for a coronavirus vaccine - using tried and tested methods for the rapid development of interventions for emerging diseases".

"Some institutions have already submitted their applications for clinical trials to the National Medical Products Administration and are planning to enroll volunteers, and they could begin after approval is granted", he said.

A vaccine for COVID-19 has been in talks for quite a while now. This will enable PHE, working with national and worldwide academic and commercial partners, to carry out rigorous evaluation and testing of vaccines and treatments that enter the clinic.

Early clinical trial results said that mRNA vaccine can generate a reliable immune response, but its efficacy is still being investigated since the technology is relatively young and there is no vaccine of its kind now on the market. According to New Scientist, if the approach works, "we will, for the first time, have identified a new disease and developed a vaccine against it while the initial outbreak is still ongoing".

Fauci emphasized that the process of developing a vaccine that's safe for widespread use will nearly certainly take a year to 18 months, and added that "anyone who thinks they're going to go more quickly than that, I believe will be cutting corners that would be detrimental".

Wang Junzhi, a senior expert on drug and vaccine development, said China is simultaneously conducting nine vaccine development projects, and a lot of them are expected to complete preclinical trials and begin human tests in April.

Canada Won't Participate in a Summer 2020 Olympic Games
On Sunday, the International Olympic Committee said it had given itself a deadline of four weeks to make a decision on the 2020 games.

The investigational vaccine, made by biotech company Moderna, does not contain any part of the actual coronavirus and can not cause infection. Following up on Moderna's announcement was another United States company called Novavax, and both companies expected that human testing would begin sometime in May/June.

Headquartered in Tübingen, close to Stuttgart, biopharmaceutical company CureVac was reportedly the target of an acquisition attempt by US President Donald Trump.

Moderna's vaccine uses messenger RNA to give the immune system a genetic blueprint for the defenses it needs. Moderna calls the vaccine mRNA-1273. Fosun Pharma will pay BioNTech up to $135m toward the project. In what some have described as a "global arms race for a coronavirus vaccine" the US, Europe & China are also engaged in the same race against time.

In a post on Twitter, Health Secretary Matt Hancock said: "Researchers at Porton Down are leading the way in developing a vaccine for Coronavirus - backed by an extra £20 million".

Dr. World Health Organization executives.

Gilead said in a statement that it will conduct two randomised studies to evaluate the effectiveness of different dosing durations of remdesivir. Patients in both groups will receive the drug for either five or 10 days.

Dr Richard Hatchett, who heads the Coalition for Epidemic Preparedness Innovations in Oslo, said, "All these timelines are aggressive and aspirational".

Other reports by

Discuss This Article